Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons

Jie Zhang1, Karl Herrup

  • 1Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

Insights

Cyclin dependent kinase 5 (Cdk5) protects neurons by suppressing cell cycle and cell death. Its non-catalytic role, dependent on p27 and p35, highlights complex regulation in neurodegenerative disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Neurodegenerative diseases often show correlated neuronal cell cycle activity and cell death.
  • The mechanistic link between these processes remains unclear.
  • Atypical cyclin-dependent kinase 5 (Cdk5) is a potential mediator.

Purpose of the Study:

  • To elucidate the role of Cdk5 in neuronal cell cycle regulation and cell death.
  • To investigate the mechanisms by which Cdk5 balances nuclear and cytoplasmic functions.
  • To understand the non-catalytic functions of Cdk5 in neurons.

Main Methods:

  • Investigated Cdk5 interactions with regulatory proteins p27 and p35.
  • Examined Cdk5 localization between the nucleus and cytoplasm.
  • Assessed Cdk5 binding to transcription factor E2F1 and its impact on DNA binding.

Main Results:

  • Cdk5 suppresses the cell cycle in the nucleus by binding E2F1, disrupting the DP1-E2F1 dimer.
  • Cdk5 suppresses cell death in the cytoplasm.
  • Cdk5 requires p27 and p35 for its non-catalytic interaction with E2F1, indicating a unique regulatory mechanism.
  • Proper levels and localization of p27 and p35 are crucial for this non-catalytic Cdk5 function.

Conclusions:

  • Cdk5 plays a dual protective role in neurons, regulating both cell cycle and cell death.
  • Neuronal cell cycle regulation by Cdk5 can occur in a non-catalytic manner, dependent on specific protein interactions.
  • Strategies targeting Cdk5 activity in neurodegenerative diseases require careful consideration due to its complex, non-catalytic roles.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...